These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8291502)

  • 1. Transient decrease of binding of insulin to platelets in acute ischemic heart disease.
    Kahn NN; Bauman WA; Sinha AK
    Am J Med Sci; 1994 Jan; 307(1):21-6. PubMed ID: 8291502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Restoration by insulin of impaired prostaglandin E1/I2 receptor activity of platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1991 Jan; 68(1):245-54. PubMed ID: 1845854
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impaired prostaglandin E1/I2 receptor activity of human blood platelets in acute ischemic heart disease.
    Kahn NN; Mueller HS; Sinha AK
    Circ Res; 1990 Apr; 66(4):932-40. PubMed ID: 2156636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of platelet aggregation and the stimulation of prostacyclin synthesis by insulin in humans.
    Kahn NN; Bauman WA; Hatcher VB; Sinha AK
    Am J Physiol; 1993 Dec; 265(6 Pt 2):H2160-7. PubMed ID: 8285255
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet prostacyclin binding in coronary artery disease.
    Jaschonek K; Karsch KR; Weisenberger H; Tidow S; Faul C; Renn W
    J Am Coll Cardiol; 1986 Aug; 8(2):259-66. PubMed ID: 3016061
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of in vitro and in vivo exposure to insulin upon prostaglandin E1 stimulation of platelet adenylate cyclase activity in healthy subjects.
    Jap TS; Kwok CF; Wong MC; Chiang H
    Diabetes Res; 1994; 27(1):39-46. PubMed ID: 7648795
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Normalization of impaired response of platelets to prostaglandin E1/I2 and synthesis of prostacyclin by insulin in unstable angina pectoris and in acute myocardial infarction.
    Kahn NN; Najeeb MA; Ishaq M; Rahim A; Sinha AK
    Am J Cardiol; 1992 Sep; 70(6):582-6. PubMed ID: 1510005
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased platelet thromboxane A2/prostaglandin H2 receptors in patients with acute myocardial infarction.
    Dorn GW; Liel N; Trask JL; Mais DE; Assey ME; Halushka PV
    Circulation; 1990 Jan; 81(1):212-8. PubMed ID: 2137044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interrelation of prostaglandin endoperoxide (prostaglandin G2) and cyclic 3',5'-adenosine monophosphate in human blood platelets.
    Salzman EW
    Biochim Biophys Acta; 1977 Aug; 499(1):48-60. PubMed ID: 196670
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Down regulation of alpha 2 adrenergic receptor numbers in platelets by insulin.
    Kahn NN; Sinha AK
    Biochim Biophys Acta; 1992 Apr; 1134(3):292-6. PubMed ID: 1313699
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMP.
    Haslam RJ; Davidson MM; Desjardins JV
    Biochem J; 1978 Oct; 176(1):83-95. PubMed ID: 215136
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cyclic AMP induces synthesis of prostaglandin E1 in platelets.
    Dayal V; Colman RW; Prakash O; Bose AK; Sinha AK
    Biochim Biophys Acta; 1983 Sep; 759(3):129-36. PubMed ID: 6309248
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Cyclic adenosine monophosphate, prostaglandin E and aggregation of blood platelets in man].
    Ardelt W
    Fortschr Med; 1977 Feb; 95(6):366-70. PubMed ID: 190100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of adenyl-cyclase activators, phosphodiesterase inhibitors and pyridoxal-5-phosphate on platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation.
    Zahavi M; Zahavi J; Kakkar VV
    Thromb Haemost; 1984 Oct; 52(2):205-9. PubMed ID: 6098048
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Octimibate, a potent non-prostanoid inhibitor of platelet aggregation, acts via the prostacyclin receptor.
    Merritt JE; Hallam TJ; Brown AM; Boyfield I; Cooper DG; Hickey DM; Jaxa-Chamiec AA; Kaumann AJ; Keen M; Kelly E
    Br J Pharmacol; 1991 Jan; 102(1):251-9. PubMed ID: 1710526
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prostaglandin E1 inhibitis platelet aggregation by a pathway independent of adenosine 3',5'-monophosphate.
    Sinha AK; Colman RW
    Science; 1978 Apr; 200(4338):202-3. PubMed ID: 204997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effet of prostaglandin E1 alone and in combination with theophylline or aspirin on collagen-induced platelet aggregation and on platelet nucleotides including adenosine 3':5'-cyclic monophosphate.
    Ball G; Brereton GG; Fulwood M; Ireland DM; Yates P
    Biochem J; 1970 Dec; 120(4):709-18. PubMed ID: 4322038
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Thrombocyte function in unstable angina pectoris].
    Terres W; Hamm CW; Kupper W; Bleifeld W
    Dtsch Med Wochenschr; 1988 Jul; 113(30):1182-6. PubMed ID: 2840254
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of pyridoxal-5-phosphate on the inhibition of platelet aggregation and adenosine-3'-5'-cyclic monophosphate accumulation in human platelets.
    Zahavi M; Zahavi J; Kakkar VV
    Life Sci; 1984 Oct; 35(14):1497-503. PubMed ID: 6090838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Systemic and transcardiac platelet activity in acute myocardial infarction in man: resistance to prostacyclin.
    Mueller HS; Rao PS; Greenberg MA; Buttrick PM; Sussman II; Levite HA; Grose RM; Perez-Davila V; Strain JE; Spaet TH
    Circulation; 1985 Dec; 72(6):1336-45. PubMed ID: 2933181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.